002390 Share Price Performance
CN¥3.80
-0.05 (-1.30%)
Price CN¥3.80
Share PriceCN¥3.80
Investor Optimism Abounds Guizhou Xinbang Pharmaceutical Co., Ltd. (SZSE:002390) But Growth Is Lacking
Feb 13
Guizhou Xinbang Pharmaceutical Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
002390 Community Narratives
There are no narratives available yet.
Guizhou Xinbang Pharmaceutical Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 29, 2025
- Earnings per share (EPS)
- 0.049
- Gross Margin
- 16.78%
- Net Profit Margin
- 1.61%
- Debt/Equity Ratio
- 10.1%
Guizhou Xinbang Pharmaceutical Co., Ltd. Competitors
Snowflake Analysis
About 002390
- Founded
- 1995
- Employees
- 5059
- CEO
- WebsiteView website
Guizhou Xinbang Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally. The company offers cardiovascular and cerebrovascular, digestive system, endocrine system, etc. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 0.6%
- 3 Months: 18.4%
- 1 Year: 24.1%
- Year to Date: 26.2%
The Materials sector gained 3.3% while the market remained flat over the last week. Meanwhile, the market is actually up 24% over the past year. Looking forward, earnings are forecast to grow by 27% annually. Market details ›